Abstract
Arthropathia in juvenile animals is the most important toxic effect induced by quinolones. We conducted pharmacokinetic and morphological studies with ofloxacin on non-human primates (Callithrix jacchus, Marmosets) and rats. In the marmoset, electron microscopy and the application of immuno-morphological methods proved to be suitable for the detection of specific alterations in cartilage (e. g. loss of proteoglycanes and altered chondrocytes). Subsequently performed electron microscopic examinations in rats showed similar specific alterations of the femur cartilage surface after multiple oral applications of 600 mg ofloxacin/kg body wt. These results were correlated with pharmacokinetic data obtained for the same species. After single oral application of 100, 300 or 600 mg ofloxacin/kg body wt to 5 week-old rats peak plasma levels were achieved 15–45 min after administration indicating a rapid absorption of the drug. The following peak concentrations were measured for the three doses applied (mean±SD): 8.9±2.1, 22.6±7.5 mg/l and 33.5±9.8 mg/l, respectively. After 360 min the concentrations were 1.1±0.4, 5.9±2.5 and 15.9±5.1 mg/l, respectively. After subcutaneous injection of 100 mg ofloxacin/kg body wt the mean peak concentration was 27.7±2.6 mg/l after 45 min (0.5±0.2 mg/l after 360 min). In the marmoset higher plasma concentrations were measured with comparable doses. One, 3, and 6 h after the last of nine administrations of 200 mg ofloxacin/kg body wt, the mean (±SD) plasma concentrations were: 42.7±16.7, 40.6±9.5, and 26.5±3.6 mg ofloxacin/l plasma. Typical alterations of the joint cartilage of juvenile rats (e. g. opened chondrocyte cavities, swelling of rough endoplasmic reticulum and mitochondrial swelling in the chondrocytes) were induced by oral administration of ofloxacin at doses that were approximately 100 times higher than therapeutic ones, but led to peak plasma concentrations which were only approximately 10 times above the therapeutic level. Since we found corresponding cartilage alterations in marmosets and rats, this species provides a convenient model for additional studies on chondrotoxic effects of quinolones.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baley RR, Natale R, Linton AL (1972) Nalidixic acid arthralgia. Can Med Assoc J 107: 604–607
Bailey RR, Kirk JA, Peddie BA (1983) Norfloxacin-induced rheumatic disease. N Z Med J 96: 590
Barrach H-J, Grundmann K, Hinz N, Felies A (1980) Immunofluorescent microscopic investigations of intercellular substances during limb development. In: H-J Merker, H Nau and D Neubert (eds) Teratology of the limbs. Walter de Gruyter, Berlin, New York, pp 273–293
Barrach H-J, Grundmann K, Hinz N, Felies A (1981) Comparison of the differentiation of muscle and connective tissue of mouse limb buds in culture and in vivo: a morphological study by indirect immunofluorescence. In: D Neubert and H-J Merker (eds) Culture techniques. Applicability for studies on prenatal differentiation and toxicity. Walter de Gruyter, Berlin, New York, pp 135–158
Borner K, Hartwig H, Lode H, Höffken G (1986) Chromatographische Bestimmung von Ofloxacin in Körperflüssigkeiten. Fresenius Z Analyt Chemie 324: 355
Chevais M, Reinert P, Rondeau MC, Tobelem R, Albengres E, Riant P, Tillement JP (1987) Critical risk/benefit analysis of pefloxacine use in children under 15 years — the problem of arthralgias. Int J Clin Pharmacol Ther Toxicol 25: 306–309
Christ W, Schmidt V (1984) Gyrase-Hemmer, mit denen sich das Bundesgesundheitsamt im Rahmen von Registrier-bzw. Zulassungsverfahren beschäftigt hat. In: W Stille et al. (eds) Gyrase-Hemmer. I. Fortschr Antimikrob Antineoplast Chemother 3–5: 795–812
Clayton DA (1982) Replication of animal mitochondrial DNA. Cell 28: 693–705
Editorial (1986) Quinolones — a paradoxical adolescence. Lancet i: 837–839
Gellert M, Mizuuchi K, O'Dea MH, Nash HA (1976) DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci 73: 3872–3876
Gough A, Barsoum NJ, Mitchell L, McGuire EJ, de la Iglesia FA (1979) Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol 51: 177–187
Hooper DC, Wolfson JS (1985) The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 28: 716–721
Höffken G, Lode H, Prinzing C, Borner K, Koeppe P (1985) Pharmacokinetics of ciprofloxacin after oral and parenteral application. Antimicrob Agents Chemother 27: 375–379
Ingham B, Brentnall DW, Dale EA, McFadzean JA (1977) Arthropathy induced by antibacterial fused N-alkyl-3-pyridone-3-carboxylic acids. Toxicol Let 1: 21–26
Kato M, Onodera T (1988 a) Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fund Appl Toxicol 11: 110–119
Kato M, Onodera T (1988 b) Morphological investigation of osteochondrosis induced by ofloxacin in rats. Fund Appl Toxicol 11: 120–131
Lode H, Höffken G, Olschewski P, Sievers B, Kirch A, Borner K, Koeppe P (1987) Pharmacokinetics of Ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother 31: 1338–1342
McDonald DF, Short HB (1964) Usefulness of nalidixic acid in treatment of urinary infection. Antimicrob Agents Chemother 4: 628–631
Melcion C, Cordier A (1986) Absence of genotoxicity of quinolones to mammalian cells. 1st Intl Quinolone Symp Geneva, (abstract) p 148
Monk JP, Campoli-Richards DM (1987) Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 33: 346–391
Neubert D (1988) Significance of pharmacokinetic variables in reproductive and developmental toxicity. Xenobiotica 18 (Suppl 1): 45–58
Neubert D, Chahoud I, Platzek T, Meister R (1987) Principles and problems in assessing prenatal toxicity. Arch Toxicol 60: 238–245
Okazaki O, Kurata T, Hashimoto K, Sudo K, Tsumura M, Tachizawa H (1984) Metabolic disposition of DL-8280. The second report: absorption, distribution and excretion of14C-DL-8280 in various animal species. Chemotherapy 32 (Suppl 1): 1185–1202
Schaad UB, Wedgwood-Krucko J (1987) Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 15: 165–168
Schlüter G (1986) Toxicology of Ciprofloxacin. In: Neu HC, Weuta H (eds) First International Ciprofloxacin Workshop, Proc Excerpta Medica, pp 61–70
Siefert HM, Maruhn D, Maul W, Förster D, Ritter W (1986 a) Pharmacokinetics of ciprofloxacin, 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. Arzneim-Forsch/Drug Res 36: 1496–1502
Siefert HM, Maruhn D, Scholl H (1986 b) Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats. Arzneim-Forsch/Drug Res 36: 1503–1510
Stahlmann R (1988) Fluoroquinolones — a new class of antimicrobial agents. Drugs of Today 24: 529–536
Stahlmann R, Lode H (1988) Safety overview: toxicity, adverse effects and drug interactions. In: VT Andriole (ed) The quinolones. Academic Press, London, pp 201–233
Stahlmann R, Chahoud I, Merker H-J, Bochert G, Webb J, Neubert D (1988 a) Arthropathogenic effects and drug plasma concentrations after administration of ofloxacin to juvenile rats. 2nd International Symp on New Quinolones, Geneva, Abstract No 137
Stahlmann R, Blankenburg G, Chahoud I, Webb J, Merker H-J, Hinz N, Neubert D (1988 b) Effects of quinolones on joint cartilage in juvenile rats and marmosets. In: D Neubert, H-J Merker, AG Hendricks (eds) Non-human primates: developmental biology and toxicology. Ueberreuter Verlag, Wien, pp 547–565
Sudo K, Hashimoto K, Kurata T, Okazaki O, Tsumura M, Tachizawa H (1984) Metabolic disposition of DL-8280. The third report: metabolism of14C-DL-8280 in various animal species, Chemotherapy 32 (Suppl 1): 1203–1210
Sudo K, Okazaki O, Tsumura M, Tachizawa H (1986) Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys. Xenobiotica 16: 725–732
Tatsumi H, Senda H, Yatera S, Takemoto Y, Yamayoshi M, Ohnishi K (1978) Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals. J Toxicol Sci 3: 357–367
Wolfson JS, Hooper DC (1985) The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 28: 581–586
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stahlmann, R., Merker, H.J., Hinz, N. et al. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol 64, 193–204 (1990). https://doi.org/10.1007/BF02010725
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02010725